Published in Hepatitis Weekly, May 25th, 1998
"The launch of this trial in Japan is another significant milestone for SciClone and its shareholders," stated Donald R. Sellers, SciClone. "It represents the culmination of over five years of cooperative development and investment and the beginning of the final stage of the Japanese...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly